NASDAQ:XENE | Free Cash Flow | Xenon Pharmaceuticals Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$88.9M$133,000.00-$89.03M
2025-12-31-$81.48M$318,000.00-$81.8M
2025-03-31-$61.65M$43,000.00-$61.7M
2024-12-31-$54.39M$783,000.00-$55.17M
2024-03-31-$46.19M$188,000.00-$46.38M
2023-12-31-$35.4M$78,000.00-$35.48M
2023-03-31-$34.41M$2.21M-$36.62M
2022-12-31-$35.33M$1.75M-$37.08M
2022-03-31-$18.43M$212,000.00-$18.64M
2021-12-31-$20.71M$514,000.00-$21.22M
2021-03-31-$20.71M$404,000.00-$21.11M
2020-12-31-$13.11M$828,000.00-$13.94M
2020-03-31-$13.07M$647,000.00-$13.71M
2019-12-31$19.79M$595,000.00$19.19M
2019-03-31-$8.67M$335,000.00-$9M
2018-12-31-$7.24M$170,000.00-$7.41M
2018-03-31-$8.22M$181,000.00-$8.4M
2017-12-31-$6.84M$63,000.00-$6.9M
2017-03-31-$6.46M$137,000.00-$6.6M
2016-12-31-$4.67M$28,000.00-$4.7M
2016-03-31-$4.94M$83,000.00-$5.03M
2015-12-31-$5.25M$143,000.00-$5.39M
2015-03-31-$5.55M$84,000.00-$5.63M
2014-12-31-$2.95M$776,000.00-$3.73M-304.49%
2014-03-31-$842,000.00$480,000.00-$1.32M-96.29%
2013-12-31-$2.69M$41,000.00-$2.73M-108.47%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$279.12M$799,000.00-$279.92M
2024-12-31-$181.39M$3.08M-$184.46M
2023-12-31-$151.11M$5.62M-$156.73M
2022-12-31-$101.03M$2.89M-$103.92M
2021-12-31-$69.5M$2.05M-$71.55M
2020-12-31-$48.12M$2.64M-$50.76M
2019-12-31-$4.71M$1.24M-$5.95M
2018-12-31-$34.72M$507,000.00-$35.23M
2017-12-31-$28.73M$315,000.00-$29.04M
2016-12-31-$19.57M$279,000.00-$19.85M
2015-12-31-$18.1M$551,000.00-$18.65M
2014-12-31$266,000.00$1.53M-$1.26M-9.70%
2013-12-31-$3.32M$156,000.00-$3.48M-28.91%
2012-12-31$45.57M$526,000.00$45.05M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.